Next Article in Journal
Brazilian Adults’ Attitudes and Practices Regarding the Mandatory COVID-19 Vaccination and Their Hesitancy towards Childhood Vaccination
Previous Article in Journal
Severity and Mortality Predictors of COVID-19 Patients with Thrombotic Events-Evidence from the “COVID-One” Hospital in Albania
 
 
Retraction of Vaccines 2022, 10(1), 2.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Retraction

Retraction: Sung et al. Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate. Vaccines 2022, 10, 2

by
Johnny Chun-Chau Sung
1,2,3,4,
Ying Liu
1,3,
Kam-Chau Wu
1,
Man-Chung Choi
1,
Chloe Ho-Yi Ma
1,
Jayman Lin
1,4,
Emily Isabel Cheng He
1,
David Yiu-Ming Leung
5,6,
Eric Tung-Po Sze
7,
Yusuf Khwaja Hamied
8,
Dominic Man-Kit Lam
4,9 and
Keith Wai-Yeung Kwong
1,2,3,8,*
1
Research Department, DreamTec Cytokines Limited, Hong Kong, China
2
Oristry BioTech (HK) Limited, Hong Kong, China
3
Meserna Therapeutic (HK) Limited, Hong Kong, China
4
L&L Immunotherapy Company Limited, Hong Kong, China
5
Zentrogene Bioscience Laboratory Limited, Hong Kong, China
6
Health Plus Laboratory Limited, Hong Kong, China
7
School of Science and Technology, Hong Kong Metropolitan University, Hong Kong, China
8
Cipla Limited, Mumbai 400013, India
9
Torsten Wiesel International Research Institute, Sichuan University, Chengdu 610017, China
*
Author to whom correspondence should be addressed.
Vaccines 2022, 10(11), 1852; https://doi.org/10.3390/vaccines10111852
Submission received: 24 October 2022 / Accepted: 27 October 2022 / Published: 1 November 2022
The journal retracts the article “Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate” [1].
Following publication, concerns were brought to the attention of the publisher regarding the ethical approval not granted from Hong Kong Metropolitan University (HKMU). In adherence to our complaints procedure, an investigation was conducted, and the article is therefore retracted. This retraction was approved by the Publication Ethics Committee and the Editor-in-Chief.
The authors agreed to this retraction.

Reference

  1. Sung, J.C.-C.; Liu, Y.; Wu, K.-C.; Choi, M.-C.; Ma, C.H.-Y.; Lin, J.; He, E.I.C.; Leung, D.Y.-M.; Sze, E.T.-P.; Hamied, Y.K.; et al. Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate. Vaccines 2022, 10, 2. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Sung, J.C.-C.; Liu, Y.; Wu, K.-C.; Choi, M.-C.; Ma, C.H.-Y.; Lin, J.; He, E.I.C.; Leung, D.Y.-M.; Sze, E.T.-P.; Hamied, Y.K.; et al. Retraction: Sung et al. Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate. Vaccines 2022, 10, 2. Vaccines 2022, 10, 1852. https://doi.org/10.3390/vaccines10111852

AMA Style

Sung JC-C, Liu Y, Wu K-C, Choi M-C, Ma CH-Y, Lin J, He EIC, Leung DY-M, Sze ET-P, Hamied YK, et al. Retraction: Sung et al. Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate. Vaccines 2022, 10, 2. Vaccines. 2022; 10(11):1852. https://doi.org/10.3390/vaccines10111852

Chicago/Turabian Style

Sung, Johnny Chun-Chau, Ying Liu, Kam-Chau Wu, Man-Chung Choi, Chloe Ho-Yi Ma, Jayman Lin, Emily Isabel Cheng He, David Yiu-Ming Leung, Eric Tung-Po Sze, Yusuf Khwaja Hamied, and et al. 2022. "Retraction: Sung et al. Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate. Vaccines 2022, 10, 2" Vaccines 10, no. 11: 1852. https://doi.org/10.3390/vaccines10111852

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop